Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 83-88 , February 2010

ABO-mismatched platelet transfusions: Strategies to mitigate patient exposure to naturally occurring hemolytic antibodies

  • Cassandra D. Josephson

      Affiliations

    • Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, United States
    • Department of Pathology, Blood and Tissue Services, Children’s Healthcare of Atlanta, Atlanta, GA, United States
    • Aflac Cancer Center and Blood Disorders Services at Children’s Healthcare of Atlanta, Atlanta, GA, United States
    • Corresponding Author InformationCorresponding author. Address: Department of Pathology, Children’s Healthcare of Atlanta at Egleston, 1405 Clifton Road, Atlanta, GA 30322, United States. Tel.: +1 404 785 4553; fax: +1 404 785 1370.
    • ,
  • Marta-Inés Castillejo

      Affiliations

    • Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, United States
    • Department of Pathology, Blood and Tissue Services, Children’s Healthcare of Atlanta, Atlanta, GA, United States
    • Aflac Cancer Center and Blood Disorders Services at Children’s Healthcare of Atlanta, Atlanta, GA, United States
    • ,
  • Kathleen Grima

      Affiliations

    • New York Blood Center, New York, NY, United States
    • ,
  • Christopher D. Hillyer

      Affiliations

    • New York Blood Center, New York, NY, United States

References 

  1. Cooling L. ABO and platelet transfusion therapy. Immunohematology. 2007;23:20–33
  2. Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma. Arch Pathol Lab Med. 2007;131:909–916
  3. Harris SB, Josephson CD, Kost CB, Hillyer CD. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion. 2007;47:1412–1417
  4. Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion. 1998;38:51–55
  5. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion. 2000;40:902–906
  6. Garratty G. Problems associated with passively transfused blood group alloantibodies. Am J Clin Pathol. 1998;109:769–777
  7. Kelton JG, Hamid C, Aker S, Blajchman MA. The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood. 1982;59:980–985
  8. Dunstan RA, Simpson MB, Knowles RW, Rosse WF. The origin of ABH antigens on human platelets. Blood. 1985;65:615–619
  9. Duquesnoy RJ, Anderson AJ, Tomasulo PA, Aster RH. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood. 1979;54:595–599
  10. Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood. 1987;70:23–30
  11. Heal JM, Rowe JM, McMican A, Masel D, Finke C, Blumberg N. The role of ABO matching in platelet transfusion. Eur J Haematol. 1993;50:110–117
  12. Lee EJ, SChiffer CA. ABO compatibility can influence the results of platelet transfusion: results of a randomized trial. Transfusion. 1989;29:384–389
  13. Carr R, Hutton JL, Jenkins JA, Lucas GF, Amphlett NW. Transfusion of ABO mismatched platelets leads to early platelet refractoriness. Br J Haematol. 1990;75:408–413
  14. Simon TL, Sierra ER. Concentration of platelet units into small volumes. Transfusion. 1984;24:173–175
  15. Moroff G, Friedman A, Robkin-Kline L, et al. Reduction of the volume of stored platelet concentrates for use in neonatal patients. Transfusion. 1984;24:144–146
  16. Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev. 2003;17:57–68
  17. Murphy MF, Hook S, Waters AH, et al. Acute haemolysis after ABO-incompatible platelet transfusion. Lancet. 1990;335:974–975
  18. Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titre iso-agglutinins: the effect of anti-A iso-agglutinins on recipients of group A. BMJ. 1942;1:659–664
  19. Tisdall LH, Garland DM, Szanto PB, Hand AM, Bonnett JC. The effects of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol. 1946;16:193–206
  20. Ebert RV, Emerson CP. A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible isoagglutinins. J Clin Invest. 1946;25:627–638
  21. Josephson CD, Mullis NC, Van Demark C, et al. Significant numbers of apheresis-derived group O platelet units have a “high-titer” anti-A/A, B: implications for transfusion policy. Transfusion. 2004;44:805–808
  22. Sadani DT, Urbaniak SJ, Bruce M, Tighes JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med. 2006;16:375–379
  23. Standards for Blood Banks and Transfusion Services, Standard 5.14.4. 24th ed. Bethesda, MD: AABB; 2006. p. 40.
  24. Commission on Laboratory Accreditation. Transfusion medicine checklist, TRM.40700 and TRM.40740. Laboratory accreditation program. Northfield, Ill: College of American Pathologists; December 2004.
  25. Conway LT, Scott EP. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletpheresis concentrate. Transfusion. 1984;24:413–414
  26. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion. 1985;25:60–62
  27. Chow MP, Yung CH, Hu HY, et al. Hemolysis after ABO-incompatible platelet transfusions. Chin Med J (Taipei). 1991;48:131–134
  28. Duguid JKM, Minards J, Bolton-Maggs PHB. Incompatible plasma transfusions and haemolysis in children. BMJ. 1999;318:176–177
  29. Valbonesi M, Deluigi MC, Lercari G, et al. Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs. 2000;23:642–646
  30. Angiolillo A, Luban NLC. Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans Cell Histiocytosis. J Pediatr Hematol Oncol. 2004;26:267–269
  31. MacLennan S. High titre anti-A/B testing of donors within the National Blood Service (NBS) (Internet). London: NBS; 2002 February, Available from http://www.blood.co.uk/hospitals/guidelines/pdf/hightit.pdf.
  32. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher. 2005;20:225–229
  33. Novotny VMJ, Brand A. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:215–216
  34. Reinhardt P, Wiesneth M, Schrezenmeier H, Seifried E. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:212–213
  35. Lundberg WB, McGinnisss MH. Hemolytic transfusion reaction due to anti-A. Transfusion. 1975;15:1–9
  36. Zoes C, Dube VE, Miller HJ, Vye MV. Anti-A1 in the plasma of platelet concentrates causing hemolytic reaction. Transfusion. 1977;17:29–32
  37. McLeod BC, Sassetti RJ, Weens JH, Vaithianathan T. Haemolytic transfusion reaction due to ABO incompatible plasma in a platelet concentrate. Scand J Haematol. 1982;28:193–196
  38. Siber GR, Ambrosino DM, Gorgone BC. Blood-group-A-like substance in a preparation of pneumococcal vaccine. Ann Int Med. 1982;96:580–586
  39. Ferguson DJ. Acute intravascular hemolysis after a platelet transfusion. CMAJ. 1988;138:523–524
  40. Reis MD, Coovadia AS. Transfusion of ABO-incompatible platelets causing severe haemolytic reaction. Clin Lab Haematol. 1989;11:237–240
  41. The Serious Hazards of Transfusion Steering Group. Serious hazards of transfusion (SHOT) 1998–1999 annual report (UK). Manchester, United Kingdom: SHOT Office; 2000, Available at http://www.shot.demon.co.uk/shot%20report%201998-99.html [accessed 2.10.09].
  42. McManigal S, Sims KL. Intravascular hemolysis secondary to ABO incompatible platelet products: underrecognized transfusion reaction. Am J Clin Pathol. 1999;111:202–206
  43. The Serious Hazards of Transfusion Steering Group. Serious hazards of transfusion (SHOT) 2000–2001 annual report (UK). Manchester, United Kingdom: SHOT Office, Available at http://www.shotuk.org/shot%20report%2000-01.pdf; 2002 [accessed 2.10.09].
  44. The Serious Hazards of Transfusion Steering Group. Serious Hazards of Transfusion (SHOT) 2003 annual report (UK). Manchester, United Kingdom: SHOT Office, Available at http://www.shotuk.org/shot%20report%202003.pdf; 2004 [accessed 2.10.09].
  45. MacLennan S. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang. 2005;88:218–219
  46. Fauzie D, Shirey RS, Thoman S, Bensen-Kennedy D, King KE. The risk of hemolytic transfusion reactions due to passively-acquired ABO antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions. Transfusion. 2004;44(Suppl.):36A;[abstract]

PII: S1473-0502(09)00181-5

doi: 10.1016/j.transci.2009.10.013

Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 83-88 , February 2010

Article Tools